FIELD: medicine, pharmaceutics.
SUBSTANCE: claimed invention deals with a pharmaceutical composition for intranasal introduction, containing mometasone furoate and azelastine hydrochloride, characterised by the fact that it contains thaumatin as the preparation for reducing bitterness and irritation.
EFFECT: reduction of bitterness and irritation is achieved.
4 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
| STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE | 2014 |
|
RU2687551C2 |
| TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE | 2019 |
|
RU2798030C2 |
| TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN | 2014 |
|
RU2799761C2 |
| COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS | 2013 |
|
RU2652352C2 |
| TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE | 2014 |
|
RU2686670C2 |
| COMPOSITION BASED ON XYLITOL, PREVENTING SEPARATION OF SLIME AND RELATED METHODS AND COMPOSITIONS | 2013 |
|
RU2607892C2 |
| COMPOSITION IN THE FORM OF EYE DROPS TO DECREASE INTRAOCULAR PRESSURE | 2017 |
|
RU2772230C2 |
| DRY PHARMACEUTICAL COMPOSITIONS CONTAINING NANOPARTICLES OF ACTIVE AGENT BOUND TO CARRIER PARTICLES | 2014 |
|
RU2715714C2 |
| THERAPEUTIC AGENT CONTAINING COMBINATION OF ACTIVE SUBSTANCES CONTAINING PANTOTHENIC ACID OR ITS DERIVATIVES FOR TREATING ALLERGIC SYMPTOMS | 2008 |
|
RU2472499C2 |
